Relationship between left ventricle geometric patterns and lymphocyte DNA damage in patients with untreated essential hypertension

Clinical Biochemistry

Volumn 40, Issue 7, 2007, Pages 454-459

  Gur, Mustafa ^a   Yildiz, Ali ^a   Demirbag, Recep ^a   Yilmaz, Remzi ^a   Koçyigit, Abdurrahim ^a   Celik, Hakim ^a   Aksoy, Nurten ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

DNA damage; Hypertension; Left ventricle geometry; Total antioxidant status

Indexed keywords

DNA;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; ESSENTIAL HYPERTENSION; FEMALE; GEOMETRY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; ANTIOXIDANTS; CHOLESTEROL; COMET ASSAY; DNA DAMAGE; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; LINEAR MODELS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LYMPHOCYTES; MALE; MIDDLE AGED; MYOCARDIUM; TRIGLYCERIDES;

EID: 33947594218     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.10.024     Document Type: Article

References (28)

1. Halliwell B., and Aruoma O. DNA damage by oxygen-derived species: its mechanism and measurement in mammalian systems. FEBS Lett. 281 (1991) 9-19
2. Ames B.N. Endogenous DNA damage as related to cancer and ageing. Free Radical Res. Commun. 7 (1989) 121-128
3. Botto N., Rizza A., Colombo M.G., et al. Evidence for DNA damage in patients with coronary artery disease. Mutat. Res. 493 (2001) 23-30
4. Schottenfeld D., and Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J. Clin. 56 (2006) 69-83
5. Demirbag R., Yilmaz R., and Kocyigit A. Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat. Res. 570 (2005) 197-203
6. Romero J.C., and Reckelhoff J.F. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34 (1999) 943-949
7. Raij L. Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy. Hypertension 31 (1998) 189-193
8. Buczynski A., Wachowicz B., Kedziora-Kornatowska K., Tkaczewski W., and Kedziora J. Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 100 (1993) 223-228
9. Ceriello A., Giugliano D., Quatraro A., and Lefebvre P.J. Anti-oxidants show antihypertensive effect in diabetic and hypertensive subjects. Clin. Sci. 81 (1991) 739-742
10. Galley H.F., Thornton J., Howdle P.D., Walker B.E., and Webster N.R. Combination oral antioxidant supplementation reduce blood pressure. Clin. Sci. 92 (1997) 361-365
11. Russo C., Olivieri O., Girelli D., et al. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J. Hypertens. 16 (1998) 1267-1271
12. Lacy F., O'Connor D.T., and Schmid-Schonbein G.W. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J. Hypertens. 16 (1998) 291-303
13. Prabha P.S., Das U.N., Koratkar R., Sagar P.S., and Ramesh G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot. Essent. Fat. Acids 41 (1990) 27-33
14. Lee J., Lee M., Kim J.K., Song K., Choi Y.S., and Cheong S.S. Carvedilol reduces plasma 8-hydroxy-2-deoxyguanosine in mild to moderate hypertension. A pilot study. Hypertension 45 (2005) 986-990
15. Ghali J.K., Liao Y., and Cooper R.S. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J. Am. Coll. Cardiol. 31 (1998) 1635-1640
16. Ganau A., Devereux R.B., Roman M.J., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J. Am. Coll. Cardiol. 19 (1992) 1550-1558
17. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
18. Teichholz L.E., Kreulen T., Herman M.V., and Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am. J. Cardiol. 37 (1976) 7-11
19. Devereux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55 (1977) 613-618
20. Singh P.N., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175 (1988) 184-191
21. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin. Biochem. 37 (2004) 112-119
22. Chen L.Y., Nichols W.W., Hendricks J., and Mehta J.L. Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis. Am. Heart J. 129 (1995) 211-218
23. Honda M., Yamada Y., Tomonaga M., Ichinose H., and Kamihira S. Correlation of urinary 8-hydroxy-2-de-oxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. Leuk. Res. 24 (2000) 461-468
24. Rice-Evans C., and Miller N.J. Total antioxidant status in plasma and body fluids. Methods Enzymol. 234 (1994) 279-293
25. Laufer E., Jennings G.L., Korner P.I., and Dewar E. Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension. Hypertension 13 (1989) 151-162
26. Cracowski J.L., Baguet J.P., Ormezzano O., et al. Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension 41 (2003) 286-288
27. Demirbag R., Yilmaz R., Gur M., et al. Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutat. Res. 578 (2005) 298-307
28. Moller P. Assessment of reference values for DNA damage detected by the comet assay in human blood cell DNA. Mutat. Res. 612 (2006) 84-104